Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo
Recommended Citation
Passeron T, Ezzedine K, Hamzavi IH, van Geel N, Schlosser BJ, Hu X, Huang X, Rosmarin D, Harris JE, Camp HS, Pandya AG. Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo. Br J Dermatol 2024; 190:II64-II65.
Document Type
Conference Proceeding
Publication Date
2-7-2024
Publication Title
Br J Dermatol
Volume
190
First Page
II64
Last Page
II65
COinS
